3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematopoietic and Lymphatic System Neoplasm
8
Breast Neoplasms
8
Lung Neoplasms
5
Prostatic Neoplasms
4
Malignant Solid Neoplasm
4
Colorectal Neoplasms
4
Ovarian Neoplasms
3
Hematologic Neoplasms
3
Thyroid Cancer, Papillary
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Multiple Myeloma
2
Mouth Neoplasms
2
Melanoma
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Head and Neck Neoplasms
2
Depression
2
Colonic Neoplasms
2
Carcinoma
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Adenocarcinoma, Follicular
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Smoking Cessation
1
Sarcoma
1
Interventions
pembrolizumab
2
durvalumab
2
Paclitaxel
2
Nivolumab
2
Ipilimumab
2
Doxorubicin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
spartalizumab
1
selinexor
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
balstilimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
Interviews as Topic
×
90 days
×
Clear all
No trials found.